Evaluation of the Sensory Attributes of Olapatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis.

Trial Profile

Evaluation of the Sensory Attributes of Olapatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Mar 2010

At a glance

  • Drugs Azelastine; Olopatadine
  • Indications Allergic rhinitis
  • Focus Pharmacodynamics
  • Sponsors Alcon
  • Most Recent Events

    • 09 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top